Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

New data analysis on Tirbanibulin shows consistent treatment response for actinic keratosis (AK): data from phase IV and real-world evidence studies show consistently high levels of response as well ...

The fight against cancer is complex and multifaceted, requiring a collective effort to create transformative change. There is a vast opportunity for collaboration to spark discussions and advance ...

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have released a new guideline outlining the steps involved for EU stakeholders, including national competent authorities, ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence and insights, today announced a partnership with Every ...

Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial Cyclin inhibitors plus endocrine ...

The European Medicines Agency (EMA) has begun the first real-world evidence (RWE) studies under its DARWIN EU initiative, kicking off three projects at the start of the “rapid ramp-up” of a program ...

Checkpoint Inhibition for Kidney Transplant Recipients With Advanced Cutaneous Carcinomas: An Emerging Standard for Select Patients Real-world data (RWD), the data relating to patient health status ...

This supplement was supported by AstraZeneca. An estimated 3.7 million adults in the United States have hyperkalemia. It commonly occurs in patients with chronic kidney disease (CKD) and/or heart ...

Most lab studies on microplastics rely on high doses and simplified conditions, raising questions about how accurately they reflect real-world human exposure and health risks. Study: Gaps between ...